Heart 2008;94:482-486
EPIDEMIOLOGY
Rose angina predicts 23-year coronary heart disease mortality in women and men aged 40–49 years
1 Norwegian Institute of Public Health, Nydalen, Oslo, Norway
2 Institute of Community Medicine, University of Tromsø, Tromsø, Norway
3 Department of Cardiology, University Hospital of North Norway, Tromsø, Norway
Correspondence to:
Dr S Graff-Iversen, Norwegian Institute of Public Health, Marcus Thranesgate 6, Box 4404 Nydalen, NO-0403 Oslo; sgri{at}fhi.no
Objective: To determine the long-term coronary heart disease (CHD) mortality in women and men with symptoms, according to the Rose Angina Questionnaire at a relatively young age.
Design: Cohort study with the baseline survey conducted during 1974–8. Information on symptoms was collected by a short, three-item version of the Rose Angina Questionnaire. Participants were re-invited to a similar survey five years later and followed for mortality throughout 2000.
Setting: Three counties in Norway (the Norwegian Counties Study).
Participants: 16 616 men and 16 265 women aged 40–49 years and denying CHD in 1974–8.
Main outcome measure: CHD mortality during 23 years.
Results: By the end of follow-up 1316 men (7.9%) and 310 women (1.9%) had died from CHD, including 16% (66/406) of men and 4% (24/563) of women with Rose angina in 1974–8. Rose angina implied an elevated mortality from CHD with adjusted hazard ratios 1.50 (95% CI 1.16 to 1.93) in men and 1.98 (95% CI 1.30 to 3.02) in women. According to calculations based on the Cox model these increases in risk are similar to those associated with elevations of total cholesterol by 1.8 mmol/l (men) and 2.5 mmol/l (women) or elevations of systolic blood pressure by 21 mm Hg (men) or 31 mm Hg (women).
Conclusions: Angina symptoms in ages as low as 40–49 years were associated with elevated long-term CHD mortality in Norwegian women and men. This indicates that the three-item version of the Rose Angina Questionnaire, although a screening tool rather than a diagnostic test, adds information on undiagnosed CHD in both sexes.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
-
All Versions of this Article:
hrt.2007.115931v1
94/4/482 most recent - Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
